US FDA urged to revise or withdraw drug/device draft classification guides
This article was originally published in Clinica
Executive Summary
Two draft guidelines by the US Food and Drug Administration on classifying medical products as drugs or medical devices has drawn concern from stakeholders, who feel the documents could result in numerous products currently classified as medical devices having to be reclassified as drugs.